[HTML][HTML] Alopecia in patients with COVID-19: A systematic review and meta-analysis

B Nguyen, A Tosti - JAAD international, 2022 - Elsevier
Background COVID-19 is associated with androgenetic alopecia (AGA), telogen effluvium
(TE), and alopecia areata (AA). No studies have analyzed the aggregate data to date …

Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management

M Ohyama, K Matsudo, T Fujita - The Journal of Dermatology, 2022 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) was declared a pandemic by the World Health …

[PDF][PDF] RETRACTED: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial

J McCoy, A Goren, FA Cadegiani… - Frontiers in …, 2021 - frontiersin.org
Antiandrogens have demonstrated a protective effect for COVOD-19 patients in
observational and interventional studies. The goal of this study was to determine if …

[HTML][HTML] Final results of a randomized, placebo-controlled, two-arm, parallel clinical trial of proxalutamide for hospitalized COVID-19 patients: a multiregional, joint …

FA Cadegiani, RA Zimerman, DN Fonseca, MN Correia… - Cureus, 2021 - ncbi.nlm.nih.gov
Background The role of androgens on COVID-19 is well established. Proxalutamide is a
second-generation, non-steroidal antiandrogen (NSAA) with the highest antiandrogen …

Lack of evidence of COVID-19 being a risk factor of alopecia areata: results of a national cohort study in South Korea

J Kim, K Hong, RE Gomez Gomez, S Kim… - Frontiers in …, 2021 - frontiersin.org
Background: Concerns about alopecia areata (AA) in coronavirus disease 2019 (COVID-19)
patients have emerged among dermatologists. However, most of the extant kinds of …

[HTML][HTML] “MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale

P Kory, GU Meduri, J Iglesias, J Varon… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Abstract In December 2019, coronavirus disease 2019 (COVID-19), a severe respiratory
illness caused by the new coronavirus severe acute respiratory syndrome coronavirus 2 …

Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia

G Guarnieri, L Bertagna De Marchi, A Marcon… - Annals of …, 2022 - Taylor & Francis
Background: A higher risk for COVID-19 infection and severity for men compared to women
has been described since the beginning of the pandemic. The role of androgens has been …

Proxalutamide improves inflammatory, immunologic, and thrombogenic markers in mild-to-moderate COVID-19 males and females: an exploratory analysis of a …

F Adsuara Cadegiani, A Goren, CG Wambier… - medRxiv, 2021 - medrxiv.org
Background The androgen theory on COVID-19 is based on the fact that males, in particular
when affected by androgenetic alopecia, and females with hyperandrogenic states are more …

[HTML][HTML] A case of rapid progression of central centrifugal cicatricial alopecia after COVID-19 infection

N Ogbuefi, T Erickson, JM Mhlaba - JAAD Case Reports, 2022 - Elsevier
Hair loss has been reported in roughly 25% of patients following infection with COVID-19. 1
Nonscarring alopecia is the most common type of hair loss seen after COVID-19 infection …

[PDF][PDF] COVID-19, new-onset alopecia, and gender distribution: a systematic review and meta-analysis

Z Akbari, M Shafie'ei, N Sarvipour… - Iranian Journal of …, 2022 - iranjd.ir
Background: Among many coronavirus disease 2019 (COVID-19) integumentary system
involvements, alopecia is one of the leastinvestigated. This disorder has been reported in …